Abstract: A packaged food product includes a container and a food product. The container has a rim and at least one sidewall extending from the rim to a bottom wall. The at least one sidewall and the bottom wall define a storage area, and the food product is retained within the storage area such that the food product is in contact with the sidewall. The sidewall is readily deformable by a hand of a user to reduce a volume of the storage area. Finger engaging recesses are formed in the bottom wall to assist in deforming the container, with reducing the volume of the storage area causing the food product to exit the storage area. The bottom wall of the container includes an integral tool portion for breaking up and/or tenderizing the food product after removal from the storage area. The food product can be a wet cat or dog food.

Abstract: The present invention provides a method of inhibiting tolerance to an opioid by a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject during opioid therapy. The pharmaceutical composition comprises a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.

Abstract: The present invention provides a method of inhibiting symptoms associated with opioid withdrawal in a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject during an opioid withdrawal period, wherein the pharmaceutical composition comprises: a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine and cetirizine and combinations thereof.

Abstract: A packaged food product includes a container and a food product. The container has a rim and at least one sidewall extending from the rim to a bottom wall. The at least one sidewall and the bottom wall define a storage area, and the food product is retained within the storage area such that the food product is in contact with the at least one sidewall. The at least one sidewall is readily deformable by a hand of a user to reduce a volume of the storage area. Finger engaging recesses are formed in the bottom wall to assist in deforming the container, with reducing the volume of the storage area causing the food product to exit the storage area. The bottom wall of the container includes an integral tool portion for breaking up and/or tenderizing the food product after removal from the storage area. The food product can be a wet cat or dog food.

Abstract: The present invention provides a method of inhibiting tolerance to an opioid by a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject during opioid therapy. The pharmaceutical composition comprises a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.

Abstract: The present invention provides a method of inhibiting tolerance to an opioid by a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject during opioid therapy. The pharmaceutical composition comprises a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.

Abstract: A packaged wet pet food product comprises a flexible container body and an integrated dispenser head for the storing and dispensing of wet pet food, specifically wet cat food or wet dog food. The flexible container body can be manually grasped and squeezed in order to deform the container body and force wet pet food stored therein to be forced through a series of exit ports formed in the dispenser head. The exit ports combine to essentially define a sieve, with the wet pet food automatically breaking into randomly sized pieces or extruded sections during dispensing, thereby advantageously avoiding the need to separately chop the pet food apart prior to consumption. The package is preferably sized to store enough pet food for multiple feedings, with the dispenser head including a cap or cover for sealing the container between uses.

Abstract: The present invention is a method of treating enteropathic arthritis in a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises: a) a non-steroidal anti-inflammatory drug (NSAID), and/or a salt thereof; and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.

Abstract: The present invention is a method of treating enteropathic arthritis in a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises: a) a non-steroidal anti-inflammatory drug (NSAID), and/or a salt thereof; and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.

Abstract: The present invention provides a method of inhibiting tolerance to an opioid by a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject during opioid therapy. The pharmaceutical composition comprises a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, cetirizine, salts thereof and combinations thereof.

Abstract: The present invention provides a method of inhibiting symptoms associated with opioid withdrawal in a human subject in need thereof. The method comprises administering an effective amount of a pharmaceutical composition to the subject during an opioid withdrawal period, wherein the pharmaceutical composition comprises: a) a non-steroidal anti-inflammatory drug (NSAID); and b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine and cetirizine and combinations thereof.

Abstract: The present invention relates to a method of reducing or preventing the symptoms associated with the common cold. The method comprises administering to a subject an effective amount of a pharmaceutical composition before presenting with at least one symptom of the common cold. The pharmaceutical composition comprises a non-steroidal anti-inflammatory drug and a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, salts thereof, and combinations thereof.